A New Weapon Against Cancer: Checkpoint Inhibitors, A Double-Edged Sword
Checkpoint inhibitors, a novel class of anticancer medications, embrace a unique approach to counter tumors.
Source: forbes.com
📰 Pd 1 News
Pd 1 News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Pd 1. Real-time updates on events, politics, business and more.
2026 VW ID.1 Makes Scripted Debut As Tiny Crossover With Targeted Sub-€20,000 Price
Volkswagen's ID.1 entry-level electric vehicle is due in 2026, and these renderings try to decipher its design. Is it a yay or a nay?
Source: autoevolution.com
Triple Combination Therapies in RCC: Clinical Trial Insights
Experts discuss the potential of triple combination therapies for high-risk renal cell carcinoma (RCC) patients and the challenges posed by their toxicity profiles, emphasizing the need for compelling clinical trial data.
Optimizing Therapy Advanced Renal Cell Carcinoma Combination Therapies Clinical Trial Insights Renal Cell Carcinoma Advanced Rcc
Source: onclive.com
Lindenwood athletes react to university cutting 10 athletic programs
Lindenwood announced in early December that 10 athletic programs, nine varsity sports, would be cut at the end of their respective seasons.For one wrestler, Lindenwood was the perfect fit until the university called a meeting on Dec. 1.
Source: firstalert4.com
ESMO 2023 Insights: SunRISe-1 Study of TAR-200 in BCG-Unresponsive Bladder Cancer
Siamak Daneshmand, MD, discusses the results of SunRISe-1 study of TAR-200, an intravesical drug delivery system, in patients with BCG-unresponsive HR NMIBC from ESMO 2023.
Source: ajmc.com
Biomarkers and Molecular/ Genomic Testing in Genitourinary Cancers
Siamak Daneshmand, MD, explores unmet needs in the bladder cancer treatment landscape at ESMO 2023.
Sia Daneshmand Muscle Invasive Non Muscle Invasive Bcg Refractory Disease Cisplatin Fgfr Targeted Therapy
Source: ajmc.com
Novel Therapies Have Significantly Improved Melanoma Outcomes, With More Exciting Options to Come
Coverage from the Institute for Value-Based Medicine session with Minnesota Oncology.
Source: ajmc.com
The Kremlin Sent An 80-Year-Old Howitzer To Ukraine
It may be the oldest artillery piece to appear so far in Russia’s 21-month wider war on Ukraine.
Donets Ka Oblast Ukraine General United States Arms Army Institute For The Study Of War Russian Occupied Donetsk
Source: forbes.com
Novel Approaches to Head and Neck Cancer at Vanderbilt Ingram Cancer Center
Speakers at an Institute for Value-Based Medicine event with Vanderbilt University Medical Center highlighted the novel therapies and techniques being used to improve outcomes for patients with head and neck cancer.
Source: ajmc.com
Study explains why certain immunotherapies don't always work as predicted | MIT News | Massachusetts Institute of Technology
An MIT study reveals a possible explanation for why checkpoint blockade inhibitors don’t work well for some patients whose tumors have a high mutational burden.
Peter Westcott Tyler Jacks Isidro Cortes Ciriano Davidh Koch Koch Institute Howard Hughes Medical Institute
Source: mit.edu